Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003

Status Completed

Clinical Trial Summary

The clinical trial was designed to evaluate the safety and immunogenicity against Group ACYW135 Meningococcal Polysaccharide Vaccine of Hualan administered on subjects 2 years of age and older.

Clinical Trial Description

Complying with requirements of the approval letter of clinical trial issued by SFDA (Approval Letter No.: 2006L01017), Hualan conducted phase III clinical trial of Group ACYW135 Meningococcal Polysaccharide Vaccine to evaluate the safety and immunogenicity of the experimental vaccine.

The safety end points were the presence of any systemic, local and adverse reaction. Evaluation indicators of immunogenicity were bacteriocin levels of groups A, C, Y and W135 respectively in the serum after the whole vaccination. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Related Conditions & MeSH terms

Meningitis

Clinical Trial Details

NCT number	NCT01661751
Study type	Interventional
Source	Hualan Biological Engineering, Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	May 2006
Completion date	August 2006

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03445416` - Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men	N/A
Completed	`NCT02526394` - Pertussis and Meningitis C Concomitant Vaccination in Adolescents	Phase 4
Completed	`NCT01442675` - Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine	Phase 2
Completed	`NCT00539032` - Immunology and Safety of Menactra® in Children in Saudi Arabia	Phase 3
Terminated	`NCT00428051` - Colombia Epidemiologic Surveillance Study	N/A
Recruiting	`NCT05496673` - Meningitis: Burden, Causes, Screening and Prevention in Rural Northern Uganda	N/A
Completed	`NCT02003495` - Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine	Phase 3
Recruiting	`NCT00901602` - Lebanese Interhospital Pneumococcal Surveillance Program
Completed	`NCT00850603` - Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®	Phase 4
Completed	`NCT02591290` - Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects	Phase 4
Completed	`NCT03112031` - Treatment With Tamoxifen in Cryptococcal Meningitis	Phase 2
Completed	`NCT02881957` - Hypovitaminosis D in Neurocritical Patients	Phase 2/Phase 3
Completed	`NCT06334796` - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology	Early Phase 1
Completed	`NCT03378258` - Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
Recruiting	`NCT05637645` - Different Approaches of Spinal Anesthesia in Patients Undergoing Cesarean Section	N/A
Completed	`NCT02841254` - Diagnostic Performance of Clinical Signs Patients Suspected of Meningitis to Emergencies	N/A
Completed	`NCT02003313` - Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine	Phase 3
Recruiting	`NCT01619462` - Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children	Phase 3
Completed	`NCT01239043` - Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination	Phase 2
Completed	`NCT00495690` - Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease	Phase 3